• vcard
D 314.552.6820
F 314.754.8329
  • Education
    • J.D., magna cum laude, The Catholic University of America, 1999
    • B.A., cum laude, Xavier University, 1996
  • Court Admissions
    • U.S. Court of Appeals, District of Columbia Circuit, 2000
    • U.S. Court of Appeals, Eighth Circuit, 2003
    • U.S. District Court, Eastern District of Missouri, 2004
    • U.S. District Court, Southern District of Illinois, 2006
    • United States Court of Federal Claims, 2009

Matthew Hans ensures that antitrust law does not prevent clients from achieving their strategic goals. He has won regulatory approval in numerous health care transactions on behalf of large non-profit health care systems, independent hospitals, physician groups and post-acute care and nursing facilities. His work frequently involves advocating for health care providers before the FTC, the DOJ Antitrust Division and state attorneys general.  Matthew guides clients through the Hart-Scott-Rodino notification process, focusing on efficient preparation of the filing and avoiding second requests or further government inquiry. In addition to health care, Matthew represents and advises public and private companies, and private equity funds in the pharmaceutical, medical device, chemical and manufacturing industries.

Matthew is a seasoned litigator advocate, having successfully represented clients in state and federal court matters involving the Sherman Act and the Clayton Act in the health care and medical device industries. He has handled trials, appeals and alternative dispute resolution in a wide range of complex commercial and business litigation. Notably, Matthew headed a team that defeated a government enforcer’s challenge to health care system’s acquisition of a physician group under Section 7 of the Clayton Act.

He uses his broad experience to develop Compliance Programs and to provide guidance, helping clients avoid problems in numerous competition issues including joint ventures, restraints of trade, exclusive dealer relationships, pricing issues and other collaborations among competitors.